Presenilin gene predisposes to late-onset degenerative but not vascular dementia: A comparative study of PS1 and ApoE genes in a North Indian cohort

Dementia and Geriatric Cognitive Disorders

Volumn 24, Issue 3, 2007, Pages 151-161

  Pandey, Pratima ^a   Pradhan, Sunil ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Alzheimer's disease; ApoE gene; Degenerative dementias; Presenilin gene; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E; PRESENILIN 1;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEGENERATIVE DEMENTIA; DEMENTIA; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HOSPITAL; HUMAN; INDIA; INTRON; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BLOOD PROTEIN ELECTROPHORESIS; COHORT STUDIES; DEMENTIA; DEMENTIA, VASCULAR; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDIA; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROPSYCHOLOGICAL TESTS; PRESENILIN-1; PSYCHIATRIC STATUS RATING SCALES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 34548188762     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000105483     Document Type: Article

References (54)

1. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K: Cloning of gene bearing missense mutation in early-onset familial Alzheimer's disease. Nature 1995;375:754-760.
2. Kovacs DM, Fausett HJ, Page KJ, Kim TW, Moir RD, Merriam DE, Hollister RD, Hallmark OG, Mancini R, Felsenstein KM, Hyman BT, Tanzi RE, Wasco W: Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membrane in mammalian cells. Nat Med 1996;2:224-229.
3. Haas C, Selkoe DJ: A technical KO of Aβ peptide. Nature 1998;391:339-340.
4. Laudon H, Hansson EM, Melen K, Bergman A, Farmery MR, Winblad B, Lendahl U, von Heijne G, Naslund J: A nine-transmembrane domain topology for presenilin 1. J Biol Chem 2005;280:35352-35360.
5. Goutte C, Tsunozaki M, Hale VA, Priess JR: APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc Natl Acad Sci USA 2002;99:775-779.
6. Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, Nicoll M, Maxwell M, Hai B, Ellis MC, Parks AL, Xu W, Li J, Gurney M, Myers RL, Himes CS, Hiebsch R, Ruble C, Nye JS, Curtis D: aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of beta-APP, and presenilin protein accumulation. Dev Cell 2002;3:85-97.
7. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song Y, Rogaeva E, Chen F, Kawarai T, Supala A, Levesque L, Yu H, Yang DS, Holmes E, Milman P, Liang Y, Zhang DM, Xu DH, Sato C, Rogaev E, Smith M, Janus C, Zhanfg Y, Aebersold R, Farree L, Sorbi S, Bruni AC, Fraser PE, St George Hyslop PH: Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and beta-APP processing. Nature 2000;407:48-54.
8. Gu Y, Sanjo N, Chen F, Hasegawa H, Petit A, Ruan X, Li W, Sheir C, Kawarai T, Schmitt UG, Westaway D, St George PH, Fraser PE: The presenilin proteins are multiple membrane-bound complexes that have different biological activities. J Biol Chem 2004;279:31329-31336.
9. Wragg M, Hutton M, Talbot C; Alzheimer's Disease Collaborative Group: Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996;347:509-512.
10. Kehoe P, Williams J, Hollmans P, Liddell M, Lovestone S, Holmes C, Powell J, Neal J, Willcock G, Owen MJ: Association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Lancet 1996;347:1185.
11. Higuchi S, Muramatsu T, Matsushita S, Arai H, Sasaki H: Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996;347:1186.
12. Isoe K, Urakami K, Ji Y, Adachi Y, Nakashima K: Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population. Acta Neurol Scand 1996;94:326-328.
13. Nishiwaki Y, Kamino K, Yoshiiwa A, Sato N, Tateishi K, Takeda M, Kobayashi T, Yamamoto H, Nonomura Y, Yoneda H, Sakai T, Imagawa M, Miki T, Ogihara T: T/G polymorphism at intron 9 of presenilin-1 gene is associated with but not responsible for sporadic late-onset Alzheimer's disease in Japanese population. Neurosci Lett 1997;227:123-126.
14. Matsushita S, Arai H, Muramatsu T, Makimoto K, Nakagawa T, Sasaki H, Higuchi S: Presenilin-1 polymorphism in Alzheimer's disease and vascular dementia. Exp Neurol 1997;146:567-569.
15. Yamada M, Sodeyama N, Itoh Y, Suematsu N, Otomo E, Matsushita M, Mizusawa H: Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly. Stroke 1997;28:2219-2221.
16. Sodeyama N, Itoh Y, Suematsu N: Presenilin-1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998;64:548-551.
17. Yasuda M, Hirono N, Maeda K, Imamura T, Mori E, Tanaka C: Case-control study of presenilin-1 intronic polymorphism in sporadic early and late-onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999;66:722-726.
18. Ezquerra M, Blessa R, Tolosa E, Pousa SL, Aguilar M, Pena J, Broeckhoven CV, Ballesta F, Oliva R: The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease. Neurosci Lett 1997;227:201-204.
19. Combarros O, Alvarez-Arcaya A, Oterino A, Berciano J, Delgado-Rodriguez M, Pena N, Fernandez-Viadero C, Luis Perez-Lopez J, Setien S, Carvajal A: Polymorphisms in the presenilin 1 and presenilin 2 genes and risk for sporadic Alzheimer's disease. J Neurol Sci 1999;171:88-91.
20. Romas SN, Mayeaux R, Tang M-X, Lantigua R, Medrano M, Tycko B, Knowles J: No association between presenilin 1 polymorphism and Alzheimer's disease. Arch Neurol 2000;57:699-702.
21. Tysoe C, Whittaker J, Cairns NJ, Atkinson PF, Harrington CR, Xuereb J, Wilcock G, Rubinsztein DC: Presenilin 1 intron 8 polymorphism is not associated with autopsyconfirmed late-onset Alzheimer's disease. Neurosci Lett 1997;222:68-69.
22. Singleton AB, Lamb H, Leake A, McKeith IG, Perry RH, Morris CM: No association between an intronic polymorphism in presenilin 1 gene and Alzheimer's disease. Neurosci Lett 1997;234:19-22.
23. Hu CJ, Sung SM, Liu HC, Chang JG: Association of apolipoprotein E genotype and intronic polymorphism of presenilin gene in Alzheimer's disease in elderly Taiwan Chinese. J Neurol Sci 1998;157:58-61.
24. Wu X, Jiang S, Lin S, Tang G, Feng G, Qian Y, Wang D, Ren D, Gu N: No association between the intronic presenilin 1 polymorphism and Alzheimer's disease in the Chinese population. Am J Med Genet 1999;88:1-3.
25. Brookes AJ, Howell WM, Woodburn K, Johnstone EC, Carothers A: Presenilin-I, presenilin-II and VLDL-R associations in early-onset Alzheimer's disease. Lancet 1997;350:336-337.
26. Lendon CL, Myers A, Cumming A, Goate AM, St Clair D: A polymorphism in the presenilin 1 gene does not modify risk for Alzheimer's disease in a cohort with sporadic early onset. Neurosci Lett 1997;228:212-214.
27. Perez-Tur J, Wavrant-De Vrieze F, Lambert JC, Chartier-Harlin MC: Presenilin-1 polymorphism and Alzheimer's disease. The Alzheimer's Study Group. Lancet 1996;347:1560-1561.
28. Korovaitseva GI, Bukina A, Farrer LA, Rogaev EI: Presenilin polymorphisms in Alzheimer's disease. Lancet 1997;350:959.
29. Bagli M, Papassotiropoulos A, Schwab SG, Jessen F, Rao ML, Maier W, Heun R: No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population. J Neurol Sci 1999;167:34-36.
30. Cai X, Stanton J, Fallin D, Hoyne J, Duara R, Gold M, Sevush S, Scibelli P, Crawford F, Mullan M: No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples. Am J Med Genet 1997;74:202-203.
31. Liao A, Gomez-Isla T, Clatworthy A, Hyman BT: Lack of association of presenilin-1 intron-8 polymorphism with neuropathological features of Alzheimer's disease. Brain Res 1999;816:295-298.
32. Scott WK, Growdon JH, Roses AD, Haines JL, Pericak-Vance MA: Presenilin 1 polymorphism and Alzheimer's disease. Lancet 1996;347:1186-1187.
33. Sorbi S, Nacmias B, Tedde A, Forleo P, Piacentini S, Latorraca S, Amaducci L: Presenilin 1 gene polymorphism in sporadic and familial Alzheimer's disease. Neurosci Lett 1997;222:132-134.
34. Chandak GR, Sridevi MU, Vas CJ, Panikker DM, Singh L: Apolipoprotein E and presenilin 1 allelic variation and Alzheimer's disease in India. Hum Biol 2002;74:683-693.
35. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-923.
36. Saunders A, Strittmatter WJ, Schmechel D, St George Hyslop P, Pericak Vance M, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
37. Luthra K, Tripathi M, Grover R, Dwivedi M, Kumar A, Dey AB: Apolipoprotein E gene polymorphism in Indian patients with Alzheimer's disease and vascular dementia. Dementia Geriatr Cogn Disord 2004;17:132-135.
38. Chapman J, Wang N, Travas TA, Korczyn AD, Borstein NM: ACE, MTHFR, factor V Leiden and APOE polymorphism in patients with vascular and Alzheimer's dementia. Stroke 1998;29:1401-1404.
39. Noguchi S, Murakami K, Yamada N: Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:737.
40. Pirttila T, Lehtimaki T, Rinne J, Mattila K, Frey H, Nilkkari T: The frequency of apolipoprotein E is not increased in patients with probable vascular dementia. Acta Neurol Scand 1996;93:352-354.
41. Kawamata J, Tanaka S, Shimohama S, Ueda K, Kimura J: Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 1994;57:1414-1416.
42. Sakoda S, Kuriyama M, Osame M, Takahashi K, Yamono T, Sasaki J, Matsunaga A: Apolipoprotein E ε4. Neurology 1994;44:2420.
43. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:215.
44. Hixon JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha1. J Lipid Res 1990;31:545-548.
45. World Health Organization: World Health Report 2003 - Shaping the Future. Geneva, World Health Organization, 2003.
46. Tsuang DW, Wilson RK, Lopez OL, Luedecking-Zimmer EK, Leverenz JB, Dekosky ST, Kamboh MI, Hamilton RL: Genetic association between the APOE *4 allele and Lewy bodies in Alzheimer's disease. Neurology 2005;64:509-513.
47. Srinivasan R, Davidson Y, Gibbons L, Payton A, Richardson AMT, Varma A, Julien C, Stopford C, Thompson J, Horan MA, Pendleton N, Pickering-Brown SM, Neary D, Snowden JS, Mann DMA: The apolipoprotein E e4 allele selectively increase the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry 2006;77:154-158.
48. Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
49. Bales KR, Verina T, Cummins DJ, Du Y, Dodel RC, Saura J, Fishman CE, DeLong CA, Piccardo P, Petegnief V, Ghetti B, Paul SM: Apolipoprotein E is essential for amyloid deposition in the APP (V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 1999;96:15233-15238.
50. Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST, et al: Apolipoprotein E polymorphism and Alzheimer's disease. The Indo-US Cross-National Dementia Study. Arch Neurol 2000;57:824-830.
51. Mastana SS, Calderon R, Pena J, Reddy PH, Papiha SS: Anthropology of the apolipoprotein E (apo E) gene: low frequency of apo E4 allele in Basques and in tribal (Baiga) populations of India. Ann Hum Biol 1998;25:137-143.
52. Gounden N, Naidoo J, Pegoraro RJ, Berger GM: Apolipoprotein E allele frequencies in a South African Indian female population. Clin Genet 1995;48:243-245.
53. Hallman DM, Boerwinkle E, Saha N, Sandholzer C, Menzel HJ, Csazar A, Utermann G: The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991;49:338-349.
54. Ikeda K, Urakami K, Arai H, Wada K, Wakutani Y, Ji Y, Adachi Y, Okada A, Kowa H, Sasaki H, Ohno K, Ohtsuka Y, Ishikawa Y, Nakashima K: The expression of presenilin 1 mRNA in skin fibroblasts and brains from sporadic Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:245-250.